Insider selling in my opinion was possible here. Smart money is waiting for the flush out, and then refilling. They need to show traction or say- x design engagments in Sensor vs the we expect fireworks in the second half.
At present, where are the sales of Zecuity + DuoResp Spiromax?
A liberal attacks the person vs the argument. Show us the money is all I'm saying vs shout out press releases. Its like the company floats balloons designated for the fourth of July, every other week. I'M a realist- I've scene many bb stocks in the past and they live/die by the next press release that may say: huge markets, patent holder, LOI, partnership agreements, etc. The difference is, legit company's (or those with CEO's who can execute biz plans) eventually show demonstrate revenue traction from these proclaimed developments. Thus far, after all of these wonderful deals and platforms, IWSY has no revenues to show. Are you now getting all of this camera guy?
We had a financial entity review and pass on implementation. Think for a minute with TARGET SAGA and other breaches, do you actually believe demand for a biometric solution to stop theft is not a high priority. IWSY lacks show dogs to get on the runway and demonstrate the best in breed, and or just incomp?
I like the technology, but even COTS, really can stay on the shelf.
Agreed- somehow like politics, the insiders seemed to find their way out of the stock before bad earnings report, go figure?
EMAN will be ripened for a fold in. Google's $3.2 billion acquisition of smart device maker Nest and Facebook's two eye-popping acquisitions -- virtual reality headset maker Oculus VR for $2 billion and messaging platform WhatsApp for $19 billion -- have garnered substantial media attention thanks to the price tags and strategic power plays involved.
to save doctors time in the ER with its software that works with Google Glass that shows providers patients’ full medical records in front of their eyes so they don’t have to toggle between terminals and charts while tending to patients.
Co-founders Yan-David Erlich and Ryan Junee are participating in a new program, “Glass for Work,” aimed at providing tools for businesses to integrate Google’s wearable device into their office setting.
Right now the software is being used by doctors at Beth Israel Deaconess Medical Center in Boston, and Erlich claims the technology has already helped to save a life. A patient came to the hospital with a massive brain bleed, and the standard course of treatment involves medications this patient was allergic to.
“Historically, doctors waste precious seconds going back to the terminal to check the information for the patient. In this case, because the doctor was wearing Google Glass, the allergies and the treatment was in his field of view without having to break eye contact with the patient, and without wasting precious seconds in the course of treatment,” Erlich says.
The duo founded Wearable Intelligence nine months ago, and has been operating in “stealth” testing mode since then, ahead of its recent live launch. The patient reaction at Beth Israel has been enthusiastic so far, Junee says.
The company has captured mobile deposit share. Despite claiming this first mover title- few depositors at these institutions have yet to engage go with/activate the product. Is it fair to assume that: once the volume of customers at each of these 2,000 banks begin to utilize mobile deposit, that revenues would coincide with the uptake in usage? In addition, if the lawsuits (which act as an anchor around the stock) land in favor of MITK, then once again, a case could be made that MITK finds itself in another advantageous position to create shareholder earnings/value?
Unit shipments (not stocking) are the golden words vs earnings (which no doubt will be negative at this stage of drug ramp/inroad process).
- During the first quarter of 2014, Alexza shipped 28,221 total units of
ADASUVE to Teva (18,788 units) and Ferrer (9,433 units)
Revenue $ 2,166 (.62) EVERYTHING above expectations.
The mobile deposit franchise is valuable given the clientele and embedded tech. See the forest through the trees scenario- As more customer sign up, then the deposit blocks will become meaningful. I see the lawsuit as the reason folk are perceptibly envisioning the company tipping on the ledge of a cliff. However, this company has been doing OCR before Jaysus, got a pair of sandals and started preaching. I remember MITK serving the medical industry a long time ago with OCR. If your believe that USAA insurance has been at their desk for a longer time doing the same things as MITK, perfecting OCR, than most are ill-judging the reality of things.
Its really bold for the analyst to make such a bold forecast. At this juncture, if he was worth his salt he'd call it undervalued and issue a buy rating.